SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
sciclone pharmaceuticals
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1137 26 0 SCLN
Emcee:  Skywatcher Type:  Unmoderated
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
12 SciClone Pharmaceuticals Launches ZADAXIN(R)Thymosin Alpha 1 in the People'Sean Lin-12/4/1996
11 Chris, I received a research report on SCLN by Meyers-Pollock-Robbins and discuSean Lin-11/14/1996
10 Statistically significant results for US hepititus C trial with Zandaxin and AlSkywatcher-11/13/1996
9 If this didn't get the price up, their will be plenty of good news coming Skywatcher-10/27/1996
8 Chris, I thought that was a very good news too. The market did not get excitedSean Lin-10/15/1996
7 Zadaxin results in Italy at Univ of Bologna show excellent results, up to 41 peSkywatcher-10/15/1996
6 Yes, very good report out on Zandaxin and it's success with Hepititus B inSkywatcher-10/4/1996
5 I bet some people learn about this news at least one day before the announcemenSean Lin-10/2/1996
4 Anyone know the reason for today's 18% increase? ALBM was also up to 30 ceSean Lin-10/2/1996
3 China approves Zandaxin for Hepititis B The People's Republic of China'Skywatcher-9/6/1996
2 market is beginning to get back to reality regarding this stock's value. NiSkywatcher-9/4/1996
1 I agree, this company has cash on hand and good management, not to mention a pJerry A. Balcolm-8/28/1996
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):